CODX vs KEYS
Co-Diagnostics, Inc. Common Stock (CODX) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
CODX currently screens at market cap $31.4M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the CODX and KEYS stock pages for the full models.
Not investment advice.